Why Novavax Stock Is in Retreat Mode Today
Shares of the vaccine-maker Novavax (NASDAQ: NVAX) are down by a hefty 12.2% as of 12:30 p.m. ET Thursday afternoon. Earlier today, the biotech announced a two-pronged strategy to address the emerging threat from the omicron variant.
Specifically, Novavax said that it is evaluating the effectiveness of its current recombinant nanoparticle protein-based vaccine, NVX-CoV2373, against the omicron variant. In addition, the biotech announced that it has begun development on an omicron-specific construct of its SARS-CoV-2 spike protein antigen.
Image source: Getty Images.
Source Fool.com
